Cariprazine (RGH-188), a D3-preferring dopamine D3/D2 receptor partial agonist antipsychotic candidate demonstrates anti-abuse potential in rats

被引：0
|
作者：
V. Román
I. Gyertyán
K. Sághy
B. Kiss
Zs. Szombathelyi
机构：
[1] Gedeon Richter Plc,Pharmacology and Drug Safety Research
[2] Gedeon Richter Plc.,Department of Behavioural Pharmacology
来源：
Psychopharmacology | 2013年 / 226卷
关键词：
Cariprazine; Aripiprazole; Bifeprunox; Dopamine receptor; Cocaine self-administration; Cocaine seeking; Relapse; Antipsychotic; Antimanic;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：285 / 293
页数：8
相关论文
共 50 条
  • [21] Cariprazine, a D3/D2 Dopamine Receptor Partial Agonist Antipsychotic, Displays Greater D3 Receptor Occupancy In Vivo Compared with Other Antipsychotics
    Kiss, Bela
    Horti, Ferenc
    Bobok, Amrita
    Adham, Nika
    BIOLOGICAL PSYCHIATRY, 2012, 71 (08) : 40S - 40S
  • [22] CARIPRAZINE, A D3/D2 DOPAMINE RECEPTOR PARTIAL AGONIST ANTIPSYCHOTIC, DISPLAYS GREATER D3 RECEPTOR OCCUPANCY IN VIVO COMPARED WITH OTHER ANTIPSYCHOTICS
    Kiss, Bela
    Horti, Ferenc
    Bobok, Amrita
    SCHIZOPHRENIA RESEARCH, 2012, 136 : S190 - S190
  • [23] CHARACTERIZATION OF CARIPRAZINE (RGH-188) D3/D2 RECEPTOR OCCUPANCY IN HEALTHY VOLUNTEERS AND SCHIZOPHRENIC PATIENTS BY POSITRON EMISSION TOMOGRAPHY (PET)
    Laszlovszky, I.
    Gage, A.
    Kapas, M.
    Ghahramani, P.
    EUROPEAN PSYCHIATRY, 2010, 25
  • [24] A convenient and practical synthesis of the cis isomer of the first orally active dopamine D3-Preferring D3-D2 receptor partial agonist cariprazine
    Yuan, Rui-Xiang
    Xu, Jun-Wei
    Song, Lian-Hua
    Qi, Yang-Li
    Mou, Hong
    Wu, Jian-Wei
    Jiang, Ke-Yu
    Chen, Xiao-Wen
    SYNTHETIC COMMUNICATIONS, 2021, 51 (14) : 2127 - 2134
  • [25] BEHAVIORAL PROFILE OF CARIPRAZINE, A DOPAMINE D3/D2 RECEPTOR PARTIAL AGONIST NOVEL ANTIPSYCHOTIC CANDIDATE, IN RODENT MODELS OF SCHIZOPHRENIA, MANIA, DEPRESSION AND COGNITION
    Gyertyan, Istvan
    Kiss, Bela
    Adham, Nika
    BEHAVIOURAL PHARMACOLOGY, 2013, 24 : E39 - E39
  • [26] Occupancy of dopamine D2 and D3 and serotonin 5-HT1A receptors by the novel antipsychotic drug candidate, cariprazine (RGH-188), in monkey brain measured using positron emission tomography
    Nicholas Seneca
    Sjoerd J. Finnema
    István Laszlovszky
    Béla Kiss
    Attila Horváth
    Gabriella Pásztor
    Margó Kapás
    István Gyertyán
    Sándor Farkas
    Robert B. Innis
    Christer Halldin
    Balázs Gulyás
    Psychopharmacology, 2011, 218 : 579 - 587
  • [27] Occupancy of dopamine D2 and D3 and serotonin 5-HT1A receptors by the novel antipsychotic drug candidate, cariprazine (RGH-188), in monkey brain measured using positron emission tomography
    Seneca, Nicholas
    Finnema, Sjoerd J.
    Laszlovszky, Istvan
    Kiss, Bela
    Horvath, Attila
    Pasztor, Gabriella
    Kapas, Margo
    Gyertyan, Istvan
    Farkas, Sandor
    Innis, Robert B.
    Halldin, Christer
    Gulyas, Balazs
    PSYCHOPHARMACOLOGY, 2011, 218 (03) : 579 - 587
  • [28] DOPAMINE D2 AND D3 RECEPTOR OCCUPANCY OF CARIPRAZINE IN SCHIZOPHRENIC PATIENTS
    Keator, David B.
    Mukherjee, J.
    Preda, A.
    Highum, D.
    Lakatos, A.
    Gage, A.
    Potkin, S. G.
    SCHIZOPHRENIA BULLETIN, 2009, 35 : 154 - 154
  • [29] Treatment of Symptom Clusters in Schizophrenia, Bipolar Disorder and Major Depressive Disorder With the Dopamine D3/D2 Preferring Partial Agonist Cariprazine
    Batinic, Borjanka
    Ristic, Ivan
    Zugic, Milica
    Baldwin, David S.
    FRONTIERS IN PSYCHIATRY, 2021, 12
  • [30] Dopamine D3 and D2 receptor occupancy of cariprazine in schizophrenic patients
    Potkin, S.
    Keator, D.
    Mukherjee, J.
    Preda, A.
    Highum, D.
    Gage, A.
    Xie, J.
    Ghahramani, P.
    Laszlovsky, I.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S316 - S316
12345